Neuroleptic malignant syndrome during zuclopenthixol therapy in X-linked cerebral adrenoleukodystrophy.

Authors :: Rubio Gozalbo, M.E.
Waardenburg, D.A. van
Forget, P.P.
Spaapen, L.J.
Verrips, A.
Vroomen, P.C.
Rubio Gozalbo, M.E.
Waardenburg, D.A. van
Forget, P.P.
Spaapen, L.J.
Verrips, A.
Vroomen, P.C.
Source :: Journal of Inherited Metabolic Disease; 605-; 6; 0141-8955; 5; 24; ~Journal of Inherited Metabolic Disease~605-~6~~~0141-8955~5~24~~
Publication Year :: 2001
Abstract: Item does not contain fulltext<br />An 8 year-old boy with X-ALD under treatment with simvastatin developed a severe adverse reaction when the dose of his other medication, zuclopenthixol was increased. Both drugs were withdrawn after a diagnosis of neuroleptic malignant syndrome was made.

Database :: OAIster
Journal :: Journal of Inherited Metabolic Disease; 605-; 6; 0141-8955; 5; 24; ~Journal of Inherited Metabolic Disease~605-~6~~~0141-8955~5~24~~
Publication Type :: Electronic Resource
Accession number :: edsoai.on1284082075
Document Type :: Electronic Resource

Tools